U.S. Capital Markets Stock News

Why NetScout Systems Is On Investors’ Radar NetScout Systems (NTCT) has drawn fresh attention after recent share price moves, with the stock posting returns of 5.2% over the past month and 22.2% over the past 3 months. Those gains have arrived alongside a value score of 4 and an indicated intrinsic discount of about 29.9%. This combination is prompting some investors to reassess how the company’s network and cybersecurity business is currently being valued. See our latest analysis for...

Last week, you might have seen that Microsoft Corporation ( NASDAQ:MSFT ) released its third-quarter result to the...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

UFP Industries, Inc. ( NASDAQ:UFPI ) just released its latest first-quarter report and things are not looking great. It...

Woodward, Inc. ( NASDAQ:WWD ) investors will be delighted, with the company turning in some strong numbers with its...

While Culp, Inc. ( NASDAQ:CULP ) might not have the largest market cap around , it received a lot of attention from a...

Some Northern Trust Corporation ( NASDAQ:NTRS ) shareholders may be a little concerned to see that the Executive VP...

Investors in Automatic Data Processing, Inc. ( NASDAQ:ADP ) had a good week, as its shares rose 9.0% to close at US$214...

Seanergy Maritime Holdings Corp. ( NASDAQ:SHIP ), is not the largest company out there, but it received a lot of...

Compañía de Minas BuenaventuraA (NYSE:BVN) reported multiple operational and permitting milestones in Q1 2026, including the production ramp up at San Gabriel. The company received key stage 1 operating and water use permits for San Gabriel, while Yumpag and El Brocal secured capacity expansion approvals. Gold production, company wide revenue, and profitability all saw significant gains in the quarter, alongside these project advances. For investors watching NYSE:BVN, these updates come...

In recent days, Gorilla Technology Group Inc. announced a significant expansion of its India AI infrastructure collaboration with Yotta Data Services, supporting the deployment of 20,736 additional B300 GPU cards in a multi-year project valued at about US$2.80 billion, alongside a deeper investment in real-time infrastructure intelligence firm Astrikos.AI. This combination of a very large GPU deployment tied to one of APAC’s largest NVIDIA DGX Cloud clusters and closer Astrikos.AI...

Wondering whether Travere Therapeutics at around US$44.12 is still offering value or if the easy gains are already behind it? This article unpacks what the current price really implies. The stock has shown strong share price moves, with returns of 8.9% over 7 days, 40.4% over 30 days, 11.6% year to date, 108.6% over 1 year, 162.6% over 3 years and 120.5% over 5 years. This naturally raises questions about both upside potential and risk. Recent headlines around Travere Therapeutics have...

Synchrony and Lowe's Companies have expanded their partnership with the launch of the MyLowe's Pro Rewards American Express Card. The new co branded card extends purchasing power and rewards for professional customers beyond Lowe's stores to any location where American Express is accepted. The offering targets small to medium business customers within Lowe's Pro segment, with a focus on broader rewards and financing flexibility. Lowe's Companies, NYSE:LOW, is trading at $233.33, with the...

Bristol-Myers Squibb (BMY) opened 2026 with Q1 revenue of US$11.5b, basic EPS of US$1.31 and net income of US$2.7b, setting the tone for how investors will judge its recent profitability. The company has seen quarterly revenue move from US$11.2b and basic EPS of US$1.21 in Q1 2025 to US$11.5b and US$1.31 in Q1 2026. Trailing twelve month EPS reached US$3.57, giving a clearer read on earnings power over the last year. With trailing net profit margin at 15% and recent earnings growth of 34.2%...

Eastman Chemical Q1 2026 earnings: headline numbers in focus Eastman Chemical (EMN) has opened 2026 with Q1 revenue of US$2.2b and basic EPS of US$0.94, setting the stage for how investors assess the latest move in profitability. Over recent quarters the company has seen revenue move between US$2.0b and US$2.3b, with basic EPS ranging from US$0.41 to US$2.85, while trailing twelve month EPS sits at US$3.49 on revenue of US$8.6b. With the stock at US$77.53 and trailing net margin at 4.6%...

T. Rowe Price Group (TROW) opened 2026 with Q1 revenue of US$1.9 billion and basic EPS of US$2.23, alongside trailing twelve month revenue of US$7.4 billion and EPS of US$9.34 that sit against modest 1.9% annual revenue growth and a 27.6% net profit margin over the past year. Over recent quarters, revenue has ranged from US$1.7 billion to US$1.9 billion, while quarterly EPS has moved between roughly US$1.93 and US$2.88. This provides a consistent picture of earnings power, even as the five...

Smokey Bones, the barbecue chain originally founded by Darden Restaurants, has been fully closed after a 27 year run. The shutdown ends a long standing brand legacy that traces back to Darden’s earlier expansion in American casual dining. Although Darden no longer owns Smokey Bones, the closure adds context for investors tracking NYSE:DRI and the broader barbecue and casual dining space. Darden Restaurants, trading as NYSE:DRI, is coming off a mixed share performance backdrop, with the...

If you are wondering whether Kimco Realty's current share price lines up with its underlying value, this article walks through the key numbers so you can judge that for yourself. Over recent periods the stock has seen mixed returns, with a 1.3% decline over the last 7 days, a 4.1% gain over 30 days, 16.6% year to date, 16.0% over 1 year, 43.7% over 3 years and 35.3% over 5 years. Recent coverage of Kimco Realty has focused on its role as a large retail REIT and how investors are weighing...

Neurocrine Biosciences (NasdaqGS:NBIX) reported new two‑year Phase 3 data from its CAHtalyst Pediatric and Adult trials of CRENESSITY in classic congenital adrenal hyperplasia. The peer‑reviewed results cover both children and adults and highlight durable efficacy alongside physiologic glucocorticoid dosing. Data show sustained reductions in harmful steroid exposure and clinical improvements, including better body mass index and insulin resistance in pediatric patients. These findings...

BioNTech, NasdaqGS:BNTX, faces potential U.S. pharmaceutical tariffs that could affect access to a key market. The company is preparing for the announced departures of its co founders from leadership roles. These developments arrive while the share price stands at $97.54 and recent returns show mixed performance across different time frames. For investors watching NasdaqGS:BNTX, these leadership changes and tariff risks are landing on a share price of $97.54, with recent moves including a...

Semtech (SMTC) is back in focus after analysts highlighted its recent track record of exceeding earnings estimates and a current positive Earnings ESP, with supportive ratings indicating firm expectations for its upcoming results. See our latest analysis for Semtech. At a share price of $107.81, Semtech has seen a 30 day share price return of 34.7% and a year to date share price return of 43.25%. Its 1 year total shareholder return of 215.88% and 3 year total shareholder return of close to 5x...

CCC Intelligent Solutions Holdings launched mobile invoice scanning in the CCC ONE platform, integrating directly into its repair management workflow. The new feature uses AI to match invoice line items to repair orders, automating parts reconciliation for repair shops. The capability is available at no additional cost to users of CCC ONE, aiming to cut manual data entry and reduce processing time. CCC Intelligent Solutions Holdings, traded as NasdaqGS:CCC, is rolling out this product...

If you are wondering whether Teradata is attractively priced or looking stretched at its current levels, you will want to understand what the valuation numbers are actually saying. The stock last closed at US$27.96, with returns of 5.8% over the past week, 10.8% over the past month, a 5.8% decline year to date, and 26.7% over the last year, alongside weaker 3 year and 5 year returns of 37.2% and 31.0% respectively. These mixed returns have kept Teradata on the radar for investors who pay...

In April 2026, Park National Corporation reported first-quarter 2026 results showing higher net interest income of US$125.78 million but slightly lower net income of US$41.69 million and earnings per share, alongside a quarterly dividend declaration of US$1.10 per share. The quarter also featured a rise in net charge-offs to US$2.63 million from US$592,000 a year earlier, putting asset quality trends in sharper focus for investors. We’ll now look at how the mix of rising net interest income...